Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 11, 2026

Warren Buffett once explained how to turn $10K into a fortune for new investors. 3 strategies that still hold up in 2026

View original at finance.yahoo.com
Warren Buffett once explained how to turn $10K into a fortune for new investors. 3 strategies that still hold up in 2026 Bill Pugliano / Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Getting to first $100,000 is the hardest part and requires being passionate about rationality, eager and opportunistic, and steadily underspending income

    80% confidence
  • Moby's stock recommendations have beaten the S&P 500 by almost 12% on average over four years across almost 400 picks

    80% confidence
  • Wealth building works like a snowball rolling down a hill due to compound interest

    80% confidence
  • Investors must be prepared for stocks to decline 50% or more and be comfortable holding through volatility

    80% confidence
  • Success comes from staying smart in specific areas rather than trying to be a genius everywhere

    80% confidence
  • If starting with $10,000 today, would focus on smaller companies because working with smaller sums means more chance something is overlooked

    80% confidence
  • Total cost of owning and operating a new vehicle in 2025 is around $12,297 per year or $1,024.71 per month

    80% confidence
  • Car insurance rates can be as low as $29 per month through comparison shopping

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com